← Back to Search

Hemodialysis Catheter

Pristine™ Long-Term Hemodialysis Catheter for Kidney Failure

N/A
Waitlist Available
Led By Jeffrey Hoggard, MD
Research Sponsored by C. R. Bard
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 3 months post index procedure.
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing the safety and performance of the Pristine™ Long-Term Hemodialysis Catheter in patients with severe kidney disease who need dialysis. The catheter is a special tube that helps these patients receive their treatments more easily. It is placed in a large vein to provide a reliable access point for dialysis.

Eligible Conditions
  • Hemodialysis Catheter Infection
  • Kidney Failure
  • Chronic Kidney Failure
  • Catheter-related Bloodstream Infection
  • Hemodialysis Complication
  • Chronic Kidney Disease
  • Hemodialysis Access Failure

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 3 months post index procedure.
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 3 months post index procedure. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Overall Complication Rate of the Pristine™ Catheter
Secondary study objectives
Overall Catheter Survival Rate
Overall Participant Survival Rate
Overall Patency Rate
+3 more
Other study objectives
Kit Component Safety and Performance

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Pristine™ Long-Term Hemodialysis CatheterExperimental Treatment1 Intervention
The Pristine™ Long-Term Hemodialysis Catheter is a chronic hemodialysis catheter consisting of a dual lumen radiopaque shaft with a pre-formed split tip, which enables long-term vascular access for hemodialysis. The device is intended to be used in patients suffering from chronic kidney disease. The Pristine™ Catheter will be placed according to the Instructions for Use (IFU).

Find a Location

Who is running the clinical trial?

C. R. BardLead Sponsor
105 Previous Clinical Trials
39,649 Total Patients Enrolled
1 Trials studying Kidney Failure
14 Patients Enrolled for Kidney Failure
Jeffrey Hoggard, MDPrincipal InvestigatorRaleigh Access Center
~42 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top